Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2024
The Role of Complement Activation in IgM M-Protein-Associated NeuropathiesJohannes P M van de Mortel, Kevin Budding, Kim Dijkxhoorn, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 10, 2021
Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complementMariona Estapé Senti, Caroline A de Jongh, Kim Dijkxhoorn, et al.European Journal of Neurology|November 15, 2024
Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2Kevin Budding, Kim Dijkxhoorn, Elisabeth de Zeeuw, et al.Blood|January 5, 2017
Polyphosphate nanoparticles on the platelet surface trigger contact system activationJohan J F Verhoef, Arjan D Barendrecht, Katrin F Nickel, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 12, 2025
IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor NeuropathyDaniëlle Krijgsman, Kim Dijkxhoorn, Elisabeth de Zeeuw, et al.Journal of Neuroinflammation|April 17, 2024
IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onsetKevin Budding, Jeroen W Bos, Kim Dijkxhoorn, et al.The Journal of Allergy and Clinical Immunology|September 14, 2020
ARGX-117, a therapeutic complement inhibiting antibody targeting C2Inge Van de Walle, Karen Silence, Kevin Budding, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor NeuropathyKevin Budding, Lill Eva Johansen, Inge Van de Walle, et al.Pageof 1